{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:40:15Z","timestamp":1771947615508,"version":"3.50.1"},"reference-count":37,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation (NRF)","doi-asserted-by":"publisher","award":["2020R1I1A2075060"],"award-info":[{"award-number":["2020R1I1A2075060"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation (NRF)","doi-asserted-by":"publisher","award":["2022R1F1A1074989"],"award-info":[{"award-number":["2022R1F1A1074989"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation (NRF)","doi-asserted-by":"publisher","award":["2022R1A4A5031503"],"award-info":[{"award-number":["2022R1A4A5031503"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Acute myeloid leukemia (AML) is characterized by the accumulation of immature myeloid cells and a differentiation block, highlighting the urgent need for novel differentiation-inducing therapies. This study evaluated Adina rubella Hance (ARH) stem as a potent differentiation inducer by systematically screening 200 plant extracts. ARH stem promoted phenotypic differentiation in AML cells. In addition to its differentiation-inducing effects, ARH stem exhibited strong antileukemic activities, such as inhibiting cell proliferation, inducing cell death, and enhancing mitochondrial reactive oxygen species (mtROS) levels, the latter of which is critical for its differentiation-promoting activity. Comparative analysis with the extracts from other parts of the plant confirmed the superior efficacy of the stem extract because of its unique chemical composition. Ultra-high-performance liquid chromatography combined with quadrupole time-of-flight mass spectrometry analysis identified Picroside III as a major active compound within the stem extract, capable of recapitulating ARH stem-induced differentiation and demonstrating significant antileukemic properties. These findings underscore the therapeutic potential of ARH stem and its active component, Picroside III, as promising agents for differentiation-based treatment strategies in AML.<\/jats:p>","DOI":"10.3390\/ijms26031350","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T04:47:31Z","timestamp":1738817251000},"page":"1350","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic Potential of Adina rubella Hance Stem and Picroside III as a Differentiation Inducer in AML Cells via Mitochondrial ROS Accumulation"],"prefix":"10.3390","volume":"26","author":[{"given":"Chan-Seong","family":"Kwon","sequence":"first","affiliation":[{"name":"Department of Integrated Biological Science, Pusan National University, Busan 46241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeol-Eun","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Integrated Biological Science, Pusan National University, Busan 46241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Eun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Integrated Biological Science, Pusan National University, Busan 46241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon-Young","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Molecular and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryun-Young","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Pusan National University, Busan 46241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keun-Hu","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Pusan National University, Busan 46241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Ju","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Pusan National University, Busan 46241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Yeon","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Pusan National University, Busan 46241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-0478","authenticated-orcid":false,"given":"Tae-Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Pusan National University, Busan 46241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Jin","family":"Shin","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Internal Medicine, Pusan National University Hospital, Busan 49241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Woo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Integrated Biological Science, Pusan National University, Busan 46241, Republic of Korea"},{"name":"Department of Biological Sciences, Pusan National University, Busan 46241, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Acute myeloid leukemia in the older adults","volume":"6","author":"Almeida","year":"2016","journal-title":"Leuk. Res. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1200\/EDBK_239097","article-title":"More versus less therapy for older adults with acute myeloid leukemia: New perspectives on an old debate","volume":"39","author":"Klepin","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2217\/fon-2022-0565","article-title":"Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the surveillance, epidemiology and end results-medicare database","volume":"19","author":"Dharmani","year":"2023","journal-title":"Future Oncol."},{"key":"ref_4","first-page":"5631","article-title":"The response to induction therapy is crucial for the treatment outcomes of elderly patients with acute myeloid leukemia: Single-institution experience","volume":"34","author":"Tasaki","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1080\/14656566.2017.1391216","article-title":"Cytarabine and daunorubicin for the treatment of acute myeloid leukemia","volume":"18","author":"Murphy","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Atilla, E., and Benabdellah, K. (2023). The black hole: CAR T cell therapy in AML. Cancers, 15.","DOI":"10.20944\/preprints202304.0482.v1"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.leukres.2016.03.010","article-title":"Effectivity of a strategy in elderly AML patients to reach allogeneic stem cell transplantation using intensive chemotherapy: Long-term survival is dependent on complete remission after first induction therapy","volume":"46","author":"Halkes","year":"2016","journal-title":"Leuk. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1182\/blood-2017-05-782292","article-title":"Midostaurin approved for FLT3-mutated AML","volume":"129","author":"Levis","year":"2017","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1902688","article-title":"Gilteritinib or chemotherapy for relapsed or refractory","volume":"381","author":"Perl","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.23736\/S0026-4806.20.07024-X","article-title":"Enasidenib and ivosidenib in AML","volume":"111","author":"Martelli","year":"2020","journal-title":"Minerva Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/s41375-019-0612-8","article-title":"How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia","volume":"33","author":"Jonas","year":"2019","journal-title":"Leukemia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1182\/blood.2023022244","article-title":"Gemtuzumab ozogamicin in AML: The next chapter","volume":"142","year":"2023","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ccell.2017.10.002","article-title":"Acute promyelocytic leukemia: A paradigm for oncoprotein-targeted cure","volume":"32","author":"Pandolfi","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: Current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Xu, Z.L., and Huang, X.J. (2020). Therapeutic approaches for acute promyelocytic leukaemia: Moving towards an orally chemotherapy-free era. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.586004"},{"key":"ref_16","first-page":"24","article-title":"Current developments on anti-inflammatory natural medicines","volume":"23","author":"Das","year":"2018","journal-title":"Neurodegener. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jep.2005.05.011","article-title":"Plants as a source of anti-cancer agents","volume":"100","author":"Cragg","year":"2005","journal-title":"J. Ethnopharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00001813-200006000-00005","article-title":"Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6","volume":"11","author":"Ishii","year":"2000","journal-title":"Anticancer Drugs"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Yin, J., Heo, J.H., Hwang, Y.J., Le, T.T., and Lee, M.W. (2016). Inhibitory activities of phenolic compounds isolated from Adina rubella leaves against 5\u03b1-reductase associated with Benign Prostatic Hypertrophy. Molecules, 21.","DOI":"10.3390\/molecules21070887"},{"key":"ref_20","first-page":"216","article-title":"A Review on pharmacological and phytochemical spectrum of \u201cTraditional medicinal plant Adina Cordifolia\u201d family-Rubiaceae","volume":"7","author":"IMT","year":"2022","journal-title":"IJASRD"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/cbdv.201500033","article-title":"Isoquinoline alkaloids from Fumaria officinalis L. and Their biological activities related to Alzheimer\u2019s Disease","volume":"13","author":"Chlebek","year":"2016","journal-title":"Chem. Biodivers."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"113637","DOI":"10.1016\/j.phytochem.2023.113637","article-title":"Isoquinoline alkaloids from Corydalis edulis Maxim. Exhibiting insulinotropic action","volume":"209","author":"Peng","year":"2023","journal-title":"Phytochemistry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"152919","DOI":"10.1016\/j.phymed.2019.152919","article-title":"Protoberberine compounds extracted from Chelidonium majus L. as novel natural photosensitizers for cancer therapy","volume":"64","author":"Warowicka","year":"2019","journal-title":"Phytomedicine"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Li, Z.R., Suo, F.Z., Guo, Y.J., Cheng, H.F., Niu, S.H., Shen, D.D., Zhao, L.J., Liu, Z.Z., Maa, M., and Yu, B. (2020). Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation. Bioorg. Chem., 97.","DOI":"10.1016\/j.bioorg.2020.103648"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Liu, T., Huang, T., Li, J., Li, A., Li, C., Huang, X., Li, D., Wang, S., and Liang, M. (2023). Optimization of differentiation and transcriptomic profile of THP-1 cells into macrophage by PMA. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0286056"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biopha.2016.04.062","article-title":"Cooperative antiproliferative and differentiation-enhancing activity of medicinal plant extracts in acute myeloid leukemia cells","volume":"82","author":"Zhamanbayeva","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1021\/acs.jnatprod.7b00722","article-title":"ent-Jungermannenone C triggers reactive oxygen species-dependent dell differentiation in leukemia cells","volume":"81","author":"Yue","year":"2018","journal-title":"J. Nat. Prod."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12185-011-0872-1","article-title":"Reactive oxygen species and hematopoietic stem cell senescence","volume":"94","author":"Shao","year":"2011","journal-title":"Int. J. Hematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.devcel.2009.05.009","article-title":"p38MAPK controls expression of multiple cell cycle inhibitors and islet proliferation with advancing age","volume":"17","author":"Wong","year":"2009","journal-title":"Dev. Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/onc.2010.419","article-title":"The p16(INK4A) tumor suppressor regulates cellular oxidative stress","volume":"30","author":"Jenkins","year":"2011","journal-title":"Oncogene"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1038\/s41388-018-0219-y","article-title":"NF\u03baB regulates p21 expression and controls DNA damage-induced leukemic differentiation","volume":"37","author":"Nicolae","year":"2018","journal-title":"Oncogene"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Huan, Q., Gao, Z., Wu, P., Zhang, Y., Xiao, H., and Peng, J. (2023). Picroside III, an active ingredient of Picrorhiza scrophulariiflora, ameliorates experimental colitis by protecting intestinal barrier integrity. Chem. Biodivers., 20.","DOI":"10.1002\/cbdv.202300572"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Sun, Y., Zhang, Y., Wang, T., Wen, L., Xing, T., Peng, J., and Liang, Y. (2023). Picroside III ameliorates colitis in mice: A study based on colon transcriptome and fecal 16S amplicon profiling. Chem. Biodivers., 20.","DOI":"10.1002\/cbdv.202301806"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.3390\/cimb45050257","article-title":"Anti-leukemic effects of Idesia polycarpa Maxim branch on human B-cell acute lymphoblastic leukemia cells","volume":"45","author":"Kwon","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lee, J.E., Kwon, C.S., Jeon, B.E., Kim, W.R., Lee, D.H., Koh, S., Kim, H.S., and Kim, S.W. (2022). Genome-wide gene expression profiling defines the mechanism of anticancer effect of colorectal cancer cell-derived conditioned medium on acute myeloid leukemia. Genes, 13.","DOI":"10.3390\/genes13050883"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1096\/fj.09-136895","article-title":"Elevated CO2 selectively inhibits interleukin-6 and tumor necrosis factor expression and decreases phagocytosis in the macrophage","volume":"24","author":"Wang","year":"2010","journal-title":"FASEB J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000351587","article-title":"Thymosin \u03b11 activates complement receptor-mediated phagocytosis in human monocyte-derived macrophages","volume":"6","author":"Serafino","year":"2014","journal-title":"J. Innate Immun."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/3\/1350\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:27:35Z","timestamp":1760027255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/3\/1350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["ijms26031350"],"URL":"https:\/\/doi.org\/10.3390\/ijms26031350","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]}}}